Rheumatology

Trials, guidelines and clinical evidence across Rheumatology.

2019 EULAR/ACR SLE criteria set ANA as entry requirement

New EULAR/ACR lupus classification criteria use ANA as an entry gate and weighted domains, improving sensitivity while preserving high specificity.

Machine learning and single-cell analysis linked osteoporosis and rheumatoid arthritis to ANO5 and IL27RA, pointing to shared immune-bone…

A genome-wide study links RNF123 to chronic widespread musculoskeletal pain, with calcium regulation and skeletal muscle emerging as…

A large GWAS links RNF123 to chronic widespread musculoskeletal pain and points to calcium regulation and skeletal muscle…

Five-year FORWARD follow-up found a dose-response in knee cartilage thickness with sprifermin and tracked long-term safety in osteoarthritis.

In a 12-month prospective trial, sulphasalazine improved rheumatoid arthritis activity faster than auranofin and was similarly tolerated.

Review examines anti-CD19 CAR T cell therapy in lupus and the expanding rationale for engineered cell therapy across…

EULAR has updated guidance on patient research partner involvement in rheumatology research, adding new principles on support, trust,…

Annals of the Rheumatic Diseases study examines how joint and skin improvement may shape health-related quality of life…

Posthoc analysis of a phase 3 trial found lower treatment failure with tocilizumab in giant cell arteritis, with…

Rheumatology

Trials, guidelines and clinical evidence across Rheumatology.

In Brief The 5-minute rounds